ALKS: Alkermes plc
ALKS exchange rate has changed by -1.38% for today. During the day, the instrument was traded at a low of 43.44 and at a high of 44.58.
Follow Alkermes plc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
ALKS News
- Earnings Preview: Alkermes (ALKS) Q3 Earnings Expected to Decline
- HRMY Stock Gains 27.6% in Six Months: Is There More Room for Growth?
- Alkermes Plans To Present Two Oral Presentations And Six Posters From Portfolio Of Sleep Medicine Research At ESRS 28th Congress, Sleep Europe 2026
- 4 CNS Drug Stocks Worth Watching This World Mental Health Day
- Stock Picks From Seeking Alpha's September 2026 New Analysts
- LQDA versus ALKS: Which Biotech Stock Is the Better Buy Now?
- Alkermes: Idiopathic Hypersomnia Could Expand LUMRYZ Into A Larger Growth, Margin Driver
- Goldman Sachs Reinstates Neutral on Alkermes, Announces $50 Price Target
- Alkermes Posts Positive Data From Phase I ADHD Study on ALKS 7290
- RBC Capital Reiterates Outperform on Alkermes, Maintains $56 Price Target
- Meta To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Tuesday
- Baird Maintains Outperform on Alkermes, Raises Price Target to $61
- Alkermes Says Experimental Drug Could Open New Path in ADHD Treatment
- Needham Reiterates Buy on Alkermes, Maintains $62 Price Target
- How Alkermes Used Its Narcolepsy Playbook In ADHD — And Seemingly Won
- Alkermes Shares Topline Results From Phase 1 Proof-of-concept Study Evaluating ALKS 7290 For Attention-deficit Hyperactivity Disorder, Showing Meaningful Improvements In Patients
- Tracking Baker Brothers' Portfolio: Q2 2026 Update
- Alkermes: A Slow-Burning Buy Prospect On Orexin-Agonist Promise (NASDAQ:ALKS)
- Trump Admin To Target Biotechs With Curbs On Drug Pricing? What Investors Should Know
- THQ Offers High-Yield Income From Healthcare Stocks (Rating Upgrade) (NYSE:THQ)
- Why Is Alkermes (ALKS) Up 1.7% Since Last Earnings Report?
Frequently Asked Questions
What is ALKS stock price today?
Alkermes plc stock is priced at 43.50 today. It trades within 43.44 - 44.58, yesterday's close was 44.11, and trading volume reached 3780. The live price chart of ALKS shows these updates.
Does Alkermes plc stock pay dividends?
Alkermes plc is currently valued at 43.50. Dividend policy depends on the company, while investors also watch 43.38% and USD. View the chart live to track ALKS movements.
How to buy ALKS stock?
You can buy Alkermes plc shares at the current price of 43.50. Orders are usually placed near 43.50 or 43.80, while 3780 and -1.41% show market activity. Follow ALKS updates on the live chart today.
How to invest into ALKS stock?
Investing in Alkermes plc involves considering the yearly range 27.00 - 55.67 and current price 43.50. Many compare 8.75% and 30.16% before placing orders at 43.50 or 43.80. Explore the ALKS price chart live with daily changes.
What are Alkermes plc stock highest prices?
The highest price of Alkermes plc in the past year was 55.67. Within 27.00 - 55.67, the stock fluctuated notably, and comparing with 44.11 helps spot resistance levels. Track Alkermes plc performance using the live chart.
What are Alkermes plc stock lowest prices?
The lowest price of Alkermes plc (ALKS) over the year was 27.00. Comparing it with the current 43.50 and 27.00 - 55.67 shows potential long-term entry points. Watch ALKS moves on the chart live for more details.
When did ALKS stock split?
Alkermes plc has gone through stock splits historically. These changes are visible in , 44.11, and 43.38% after corporate actions.
- Previous Close
- 44.11
- Open
- 44.12
- Bid
- 43.50
- Ask
- 43.80
- Low
- 43.44
- High
- 44.58
- Volume
- 3.780 K
- Daily Change
- -1.38%
- Month Change
- 8.75%
- 6 Months Change
- 30.16%
- Year Change
- 43.38%
- Act
- -3.060 M
- Fcst
- -4.804 M
- Prev
- -8.557 M
- Act
- 0.987 M
- Fcst
- -0.153 M
- Prev
- 1.862 M
- Act
- Fcst
- Prev
- 5.420%